back to Actors and Projects

PlusMe: Transitional Wearable Companions for the therapy with children with Autism Spectrum Disorders

Start Date: 01-09-2020

End Date: 28-02-2022

Id: PlusMe

CORDIS identification number: 945887

\me is an experimental soft interactive toy with a panda form designed in collaboration with developmental therapists. Thanks to embedded electronics, \me can emit attractive responses as colored lights and amusing sounds when touched on paws. The device is connected to a control tablet to allow an adult caregiver to modify the input-output contingencies, so as to produce several rewarding response patterns according to child’s reaction. These features make \me a potential support tool for therapy of children with Autism Spectrum Disorders (ASD): the attractiveness and the functional versatility of the device could be exploited during play activities with a therapist to capture the interest of children, to encourage their social interactions, then reinforcing pivotal social skills as imitation, eye-contact, turn-taking. \me is currently in experimental phase, in pilot tests on children (24-48 months) with ASD and Typical Development (TD). The experiments are conducted in collaboration with the Sec. of Child and Adolescent Neuropsychiatry -Univ. of Rome “Sapienza”- whose researchers showed great interest to technological aid for therapy. \me is an indirect -yet really promising- outcome of the ongoing FET project “Goal-based Open-ended Autonomous Learning Robots, GOAL-Robots” (Grant Agreement No. 713010). The main goal of the proposal is to develop the \me from the current experimental prototype towards a “ready-for-market” product, certified for safe use in EU. The proposal aims to 1) engineer the prototype, through a third party company expert in electronic manufacturing, in order to realise a small-scale production of 10/20 working \me samples; 2) at the same time, continue the experimentation on TD and ASD children, to strengthen the scientific aspects of the device; 3) disclose the obtained results through scientific publications and participation to promotional events market-oriented, in forecast of a next possible commercialisation.